These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23951230)

  • 1. Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzyme.
    Vallières C; Fisher N; Meunier B
    PLoS One; 2013; 8(8):e71726. PubMed ID: 23951230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
    Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
    Song Z; Clain J; Iorga BI; Yi Z; Fisher N; Meunier B
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4053-8. PubMed ID: 25918152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
    Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.
    Korsinczky M; Chen N; Kotecka B; Saul A; Rieckmann K; Cheng Q
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2100-8. PubMed ID: 10898682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.
    Dong CK; Urgaonkar S; Cortese JF; Gamo FJ; Garcia-Bustos JF; Lafuente MJ; Patel V; Ross L; Coleman BI; Derbyshire ER; Clish CB; Serrano AE; Cromwell M; Barker RH; Dvorin JD; Duraisingh MT; Wirth DF; Clardy J; Mazitschek R
    Chem Biol; 2011 Dec; 18(12):1602-10. PubMed ID: 22195562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
    Siregar JE; Syafruddin D; Matsuoka H; Kita K; Marzuki S
    Parasitol Int; 2008 Jun; 57(2):229-32. PubMed ID: 18248769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
    Murithi JM; Owen ES; Istvan ES; Lee MCS; Ottilie S; Chibale K; Goldberg DE; Winzeler EA; Llinás M; Fidock DA; Vanaerschot M
    Cell Chem Biol; 2020 Feb; 27(2):158-171.e3. PubMed ID: 31813848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
    Kessl JJ; Meshnick SR; Trumpower BL
    Trends Parasitol; 2007 Oct; 23(10):494-501. PubMed ID: 17826334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug-selected Plasmodium falciparum lacking the need for conventional electron transport.
    Smilkstein MJ; Forquer I; Kanazawa A; Kelly JX; Winter RW; Hinrichs DJ; Kramer DM; Riscoe MK
    Mol Biochem Parasitol; 2008 May; 159(1):64-8. PubMed ID: 18308406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of
    Lane KD; Mu J; Lu J; Windle ST; Liu A; Sun PD; Wellems TE
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6285-6290. PubMed ID: 29844160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.
    Vallières C; Fisher N; Antoine T; Al-Helal M; Stocks P; Berry NG; Lawrenson AS; Ward SA; O'Neill PM; Biagini GA; Meunier B
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3739-47. PubMed ID: 22547613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action.
    Birth D; Kao WC; Hunte C
    Nat Commun; 2014 Jun; 5():4029. PubMed ID: 24893593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
    Fisher N; Abd Majid R; Antoine T; Al-Helal M; Warman AJ; Johnson DJ; Lawrenson AS; Ranson H; O'Neill PM; Ward SA; Biagini GA
    J Biol Chem; 2012 Mar; 287(13):9731-9741. PubMed ID: 22282497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition Mechanism of Antimalarial Drugs Targeting the Cytochrome bc
    Jacobsen L; Husen P; Solov'yov IA
    J Chem Inf Model; 2021 Mar; 61(3):1334-1345. PubMed ID: 33617262
    [No Abstract]   [Full Text] [Related]  

  • 19. The antimalarial compound ELQ-400 is an unusual inhibitor of the bc
    Song Z; Iorga BI; Mounkoro P; Fisher N; Meunier B
    FEBS Lett; 2018 Apr; 592(8):1346-1356. PubMed ID: 29574797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between the hinge region of iron sulphur protein and the Qo site in the bc1 complex - Analysis of Plasmodium-like mutations in the yeast enzyme.
    Song Z; Clain J; Iorga BI; Vallières C; Lalève A; Fisher N; Meunier B
    Biochim Biophys Acta; 2015 Dec; 1847(12):1487-94. PubMed ID: 26301481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.